IQVIA HOLDINGS INC. (IQV)
Data as of , from SEC Form 4 filings.
See up to 3 months of IQV. The 7-day demo opens the 1M and 3M ranges and puts IQV on your watchlist.
Start 7-day demoLatest IQV insider trades
- James G. Berkshire - OfficerOpen-market sale$697K
- W. Richard Staub - OfficerOpen-market sale$1.28M
About IQVIA HOLDINGS INC. (IQV)
IQVIA HOLDINGS INC. files with the SEC under CIK 0001478242 and is classified as commercial physical and biological research. It is grouped with Health Care companies on this site.
IQV Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 9 | 121,860 | $29.89M |
| Option exercise | 4 | 323,174 | |
| Derivative transaction | 3 | 52,640 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
IQV insider transactions (Form 4)
4070 Form 4 filings on record, the earliest from Nov 8, 2024, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| James G. Berkshire - Officer | Option exercise | Common Stock | 5,381 | $131.82 | $709K | |
| James G. Berkshire - Officer | Open-market sale | Common Stock | 2,668 | $261.33 | $697K | |
| James G. Berkshire - Officer | Derivative | Common Stock | 2,713 | $261.54 | $710K | |
| James G. Berkshire - Officer | Option exercise | Stock Appreciation Right | 5,381 | $131.82 | $709K | |
| W. Richard Staub - Officer | Open-market sale | Common Stock | 5,500 | $232.68 | $1.28M | |
| Bhavik Patel - Officer | Open-market sale | Common Stock | 1,855 | $235.27 footnote F1 | $436K | |
| ||||||
 Eric Sherbet - Officer | Open-market sale | Common Stock | 5,000 | $249.16 | $1.25M | |
 Keriann Cherofsky - Officer | Open-market sale | Common Stock | 558 | $245.21 | $137K | |
| Ari Bousbib - Officer | Option exercise | Common Stock | 156,206 footnote F1 | $78.21 | $12.22M | |
| Ari Bousbib - Officer | Open-market sale | Common Stock | 4,465 footnote F1 | $247.10 footnote F2 | $1.10M | |
| Ari Bousbib - Officer | Open-market sale | Common Stock | 4,584 footnote F1 | $246.85 footnote F3 | $1.13M | |
| Ari Bousbib - Officer | Open-market sale | Common Stock | 44,039 footnote F1 | $246.08 footnote F4 | $10.84M | |
| Ari Bousbib - Officer | Open-market sale | Common Stock | 53,191 footnote F1 | $244.78 footnote F5 | $13.02M | |
| Ari Bousbib - Officer | Derivative | Common Stock | 47,858 footnote F1 | $244.60 | $11.71M | |
| Ari Bousbib - Officer | Derivative | Common Stock | 2,069 footnote F1 | $247.00 | $511K | |
| Ari Bousbib - Officer | Option exercise | Stock Appreciation Right | 156,206 | $78.21 | $12.22M | |
| ||||||
 Morris Leslie Wims - Director | Grant or award | Deferred Shares | 148 | $207.83 | $31K | |
 Colleen A. Goggins - Director | Grant or award | Deferred Shares | 183 | $207.83 | $38K | |
| Jim Fasano - Director | Grant or award | Deferred Shares | 195 | $207.83 | $41K | |
 John G. Danhakl - Director | Grant or award | Deferred Shares | 160 | $207.83 | $33K | |
| Morris Leslie Wims - Director | Grant or award | Deferred Shares | 171 | $178.64 | $31K | |
| Colleen A. Goggins - Director | Grant or award | Deferred Shares | 214 | $178.64 | $38K | |
| Jim Fasano - Director | Grant or award | Deferred Shares | 228 | $178.64 | $41K | |
| John G. Danhakl - Director | Grant or award | Deferred Shares | 185 | $178.64 | $33K | |
| Sheila A. Stamps - Director | Grant or award | Deferred Shares | 1,571 | $160.68 | $252K | |
| Morris Leslie Wims - Director | Grant or award | Deferred Shares | 1,571 | $160.68 | $252K | |
| William G. Kaelin Jr. - Director | Grant or award | Deferred Shares | 1,571 | $160.68 | $252K | |
| John M. Leonard - Director | Grant or award | Common Stock | 1,571 footnote F1 | $0.00 | - | |
| ||||||
| Colleen A. Goggins - Director | Grant or award | Common Stock | 1,571 footnote F1 | $0.00 | - | |
| ||||||
| Jim Fasano - Director | Grant or award | Deferred Shares | 1,571 | $160.68 | $252K | |
| John G. Danhakl - Director | Grant or award | Common Stock | 1,571 footnote F1 | $0.00 | - | |
| ||||||
| Carol Burt - Director | Grant or award | Common Stock | 1,571 footnote F1 | $0.00 | - | |
| ||||||
| Bernd Haas - Officer | Tax withholding / forfeiture | Common Stock | 20 | $166.94 | $3K | |
| Michael J. Fedock - Officer | Tax withholding / forfeiture | Common Stock | 123 | $166.94 | $21K | |
| W. Richard Staub - Officer | Grant or award | Stock Appreciation Right | 26,088 | $0.00 | - | |
| Eric Sherbet - Officer | Grant or award | Stock Appreciation Right | 12,112 | $0.00 | - | |
| Bhavik Patel - Officer | Grant or award | Stock Appreciation Right | 11,180 | $0.00 | - | |
| Bernd Haas - Officer | Grant or award | Stock Appreciation Right | 11,180 | $0.00 | - | |
| Alistair Grenfell - Officer | Grant or award | Stock Appreciation Right | 26,088 | $0.00 | - | |
| Michael J. Fedock - Officer | Grant or award | Stock Appreciation Right | 18,634 | $0.00 | - | |
Item 1.01, 2.03, 9.01
Item 8.01, 9.01
Item 2.02, 9.01
Item 1.01, 2.03, 9.01
Recent IQV Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| JAMES G BERKSHIRE | Officer | 2,668 | $697K | View on EDGAR | |
| WALTER STAUB | Officer | 5,500 | $1.28M |
Stock trades in IQV disclosed by members of the U.S. House in the last 12 months, newest first. Values are the ranges as filed.
| Member | Type | Traded | Disclosed | Value range | Owner | Days to disclose | Filing |
|---|---|---|---|---|---|---|---|
 Kevin HernRepublican, OK-01 | Sale |
IQV insider trading FAQ
What is the latest insider trade for IQV?
IQVIA HOLDINGS INC. (IQV) had 6 insider filings in the last 90 days, with the most recent on 2026-09-04. The full record for IQV runs to 70 Form 4 filings, the earliest from 2024-11-08. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying IQV stock?
No insider purchases of IQV were filed in the last 90 days.
How many insiders are selling IQV stock?
9 insider sales of IQV were filed in the last 90 days, totaling $29.89M.
Where can I see IQV SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects IQV Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - James G. Berkshire view on EDGAR
- - W. Richard Staub view on EDGAR
- - Bhavik Patel view on EDGAR
- - Eric Sherbet view on EDGAR
- - Keriann Cherofsky view on EDGAR
- - Ari Bousbib view on EDGAR
- - Morris Leslie Wims view on EDGAR
- - Colleen A. Goggins view on EDGAR
- - Jim Fasano view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where IQV's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow IQV with a 7-day demo
- IQV on your watchlist
- Every IQV Form 4 filing on record
- Up to 3 months of IQV price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
